CD8A and neoplasm: Mechanistically, CD4+ T cell activation through MHC‐II‐dependent pathways suppresses myeloid‐derived osteopontin, which otherwise induces the activation of the chronic nuclear factor of activated T cells, cytoplasmic 1, in tumor‐reactive CD8+ T cells.